These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15301922)

  • 1. Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Yamauchi M; Tatebayashi T; Nagase K; Kojima M; Imanishi T
    Pharmacol Biochem Behav; 2004 Aug; 78(4):683-9. PubMed ID: 15301922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors.
    Yamauchi M; Miyara T; Matsushima T; Imanishi T
    Brain Res; 2006 Jan; 1067(1):164-9. PubMed ID: 16360124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.
    Kennett GA; Lightowler S; de Biasi V; Stevens NC; Wood MD; Tulloch IF; Blackburn TP
    Neuropharmacology; 1994 Dec; 33(12):1581-8. PubMed ID: 7760981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors].
    Yamauchi M; Hiraoka S; Imanishi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):193-8. PubMed ID: 17240844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
    Fujitsuka N; Asakawa A; Hayashi M; Sameshima M; Amitani H; Kojima S; Fujimiya M; Inui A
    Biol Psychiatry; 2009 May; 65(9):748-59. PubMed ID: 19058784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors.
    Nonogaki K; Nozue K; Takahashi Y; Yamashita N; Hiraoka S; Kumano H; Kuboki T; Oka Y
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):675-81. PubMed ID: 16959056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene.
    Nonogaki K; Ohba Y; Wakameda M; Tamari T
    Int J Neuropsychopharmacol; 2009 May; 12(4):547-52. PubMed ID: 18976545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSRI treatment decreases prolactin and hyperthermic responses to mCPP.
    Quested DJ; Sargent PA; Cowen PJ
    Psychopharmacology (Berl); 1997 Oct; 133(3):305-8. PubMed ID: 9361338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
    Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
    Egashira N; Harada S; Okuno R; Matsushita M; Nishimura R; Mishima K; Iwasaki K; Orito K; Fujiwara M
    Eur J Pharmacol; 2007 Jun; 563(1-3):149-54. PubMed ID: 17349995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear.
    Li XB; Inoue T; Hashimoto S; Koyama T
    Eur J Pharmacol; 2001 Aug; 425(1):43-50. PubMed ID: 11672573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
    Kennett GA; Wood MD; Bright F; Trail B; Riley G; Holland V; Avenell KY; Stean T; Upton N; Bromidge S; Forbes IT; Brown AM; Middlemiss DN; Blackburn TP
    Neuropharmacology; 1997; 36(4-5):609-20. PubMed ID: 9225286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    McMahon LR; Cunningham KA
    Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.
    Nic Dhonnchadha BA; Ripoll N; Clénet F; Hascoët M; Bourin M
    Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
    Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
    Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Sánchez C; Meier E
    Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of paroxetine on marble-burying behavior in mice.
    Shinomiya K; Fujii Y; Sugimoto Y; Azuma N; Tokunaga S; Kitazumi K; Kamei C
    Methods Find Exp Clin Pharmacol; 2005 Dec; 27(10):685-7. PubMed ID: 16395417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.